Relias Valerie, Saif Muhammad Wasif
Division of Hematology/Oncology and Experimental Therapeutics, Tufts Medical Center. Boston, MA, USA.
JOP. 2014 Jul 28;15(4):306-7. doi: 10.6092/1590-8577/2674.
Ampullary adenocarcinomas have unique biologic and clinical features that result in its improved prognosis versus adenocarcinomas that arise from the distal bile ducts and pancreas. However the histological differentiation and identification of these tumors is not easily accomplished. Two abstracts at this year's ASCO Annual Meeting describe attempts to identify unique methods for distinguishing these tumors. Abstract #4141 described a 92 gene RT-PCR assay that was used for molecular classification of patients with ampullary adenocarcinomas while Abstract #e15175 looked at mutational status of K-ras in patients with these tumors. The results of their abstracts will be discussed.
壶腹腺癌具有独特的生物学和临床特征,与起源于远端胆管和胰腺的腺癌相比,其预后较好。然而,这些肿瘤的组织学分化和鉴定并非易事。在今年的美国临床肿瘤学会(ASCO)年会上,有两篇摘要描述了识别区分这些肿瘤的独特方法的尝试。摘要#4141描述了一种92基因逆转录聚合酶链反应(RT-PCR)检测方法,用于壶腹腺癌患者的分子分类,而摘要#e15175则研究了这些肿瘤患者的K-ras突变状态。将对其摘要结果进行讨论。